1,919 results on '"Cleton, A."'
Search Results
2. Formalin-Fixed, Paraffin-Embedded–Targeted Locus Capture: A Next-Generation Sequencing Technology for Accurate DNA-Based Gene Fusion Detection in Bone and Soft Tissue Tumors
3. A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target
4. Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
5. The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis
6. Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia
7. Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
8. The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS Analysis.
9. SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin
10. The role of mesenchymal stem cells in bone cancer
11. Zebrafish models for studying bone tumors
12. Intersectional migration research: Re‐centring governance structures
13. Fundamentele aspecten van kanker
14. Het uitzetten van geïllegaliseerde kinderen uit Nederland en België: Waarom legitimatiewerk van ambtenaren moet leiden tot het heroverwegen van burgerschap.
15. Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing
16. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation
17. Gendered Migrations
18. Co-constructions of family and belonging in the politics of family migration
19. A screening-based approach identifies cell cycle regulators AURKA, CHK1 and PLK1 as targetable regulators of chondrosarcoma cell survival
20. Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer
21. The Next Step to Further Decrease Veterinary Antibiotic Applications: Phytogenic Alternatives and Effective Monitoring; the Dutch Approach
22. Risk factors associated with sustained circulation of six zoonotic arboviruses: a systematic review for selection of surveillance sites in non-endemic areas
23. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft
24. Immune checkpoint inhibitors in sarcomas: in quest of predictive biomarkers
25. Early Activation of the Innate Immunity and Specific Cellular Immune Pathways after Vaccination with a Live Intranasal Viral Vaccine and Challenge with Bovine Parainfluenza Type 3 Virus
26. Soft tissue aneurysmal bone cyst: six new cases with imaging details, molecular pathology, and review of the literature
27. Exposure–response relationship of regorafenib efficacy in patients with hepatocellular carcinoma
28. The time politics of migrant deportability: an intersectional analysis of deportation policy for non-citizen children in Belgium and the Netherlands
29. A screening-based approach identifies cell cycle regulators AURKA, CHK1 and PLK1 as targetable regulators of chondrosarcoma cell survival
30. Tussen dwang en drang
31. Contesting policy categories using intersectionality: reflections for studying migration governance.
32. Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line
33. Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression
34. Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
35. Saving the Children. Humanitarianism, Internationalism, and Empire
36. Supplementary Data from Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors
37. Supplementary material from Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression
38. Supplementary Data from Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents
39. Supplementary Figure 2 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
40. Supplementary Figure 1 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
41. Supplementary Figure 1 from Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer
42. Supplementary Methods, Figure Legends 1-3, Table Legends 1-6 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
43. Supplementary Table 1 from Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer
44. Supplementary Tables 1-6 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
45. Supplementary Table 2 from Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer
46. Data from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
47. Supplementary Methods and Materials from Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer
48. Supplementary Figure 3 from Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
49. No NFATC2 fusion in simple bone cyst of the jaw
50. Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.